CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 12th Annual BIO CEO & Investor Conference at 2:30 p.m. EST on February 8, 2010, in New York City.
